| INSULET CORP. DL -,001 |
| USA |
| Gesundheit |
| US45784P1012 / A0MQX8 |
| GOV (Frankfurt) / PODD (NASDAQ) |
| FRA:GOV, ETR:GOV, GOV:GR, NASDAQ:PODD |
| - |
| https://www.insulet.com/ |
|
Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-dependent diabetes worldwide. The Omnipod offers a tub..
>Volltext.. |
| 9216.13 Mio. EUR |
| 9620.9 Mio. EUR |
| 2492.31 Mio. EUR |
| 537.57 Mio. EUR |
| 260.15 Mio. EUR |
| 3.7 EUR |
| 814.56 Mio. EUR |
| 412.74 Mio. EUR |
| - |
| 0.7 |
| 23.53% |
| -29.5% |
| - |
| - |
| - |
| - |
| INSULET |
| 27.05.26 |
|